Deregulation of the cytoplasmic tyrosine kinase cSrc in the absence of a truncating mutation at codon 531 in human bladder carcinoma

被引:17
作者
Bénistant, C [1 ]
Chapuis, H
Mottet, N
Noletti, J
Crapez, E
Bali, JP
Roche, S
机构
[1] CNRS, UPR 1086, Montpellier, France
[2] CHU, Dept Urol, Nimes, France
[3] CRLC Val Daurelle Paul Lamarque, Montpellier, France
[4] Fac Pharm, Montpellier, France
关键词
D O I
10.1006/bbrc.2000.2948
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The involvement of the cytoplasmic tyrosine kinase cSrc was investigated in human bladder carcinogenesis. Kinase activity was determined in tissue lysates from bladder transitional cell carcinoma (TCC) relative to normal epithelia. Strong kinase activation was observed at all stages of carcinogenesis with a peak at the stage pT1, where tumor cells disrupt the basement membrane and invade the submucosa. In agreement with a role for cSrc in cell invasion, immunocytochemistry analysis showed a strong staining of invading cells. An increase in cSrc protein level were also found in most tumor samples, however, it did not correlate with an increase in activity (r = 0.44) suggesting that cSrc is deregulated in these tumors. Indeed, high Src activity was affinity-purified from a column (IRSVSSDGHE(p)YIYVDP-Affigel 10) that specifically retains active Src. Enzymatic regulation involves the C-terminus, recently found mutated at codon 531 in a subset of advanced human colon cancers. However, no such mutations were detected in TCC, suggesting the existence of other mechanisms for kinase activation. (C) 2000 Academic Press.
引用
收藏
页码:425 / 430
页数:6
相关论文
共 33 条
  • [1] ACTIVATION OF PP60C-SRC PROTEIN-KINASE ACTIVITY IN HUMAN-COLON CARCINOMA
    BOLEN, JB
    VEILLETTE, A
    SCHWARTZ, AM
    DESEAU, V
    ROSEN, N
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) : 2251 - 2255
  • [2] Src and Ras are involved in separate pathways in epithelial cell scattering
    Boyer, B
    Roche, S
    Denoyelle, M
    Thiery, JP
    [J]. EMBO JOURNAL, 1997, 16 (19) : 5904 - 5913
  • [3] CAIRNS P, 1991, ONCOGENE, V6, P2305
  • [4] CAIRNS P, 1993, CANCER RES, V53, P1230
  • [5] ELEVATED C-SRC TYROSINE KINASE-ACTIVITY IN PREMALIGNANT EPITHELIA OF ULCERATIVE-COLITIS
    CARTWRIGHT, CA
    COAD, CA
    EGBERT, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) : 509 - 515
  • [6] ACTIVATION OF THE PP60C-SRC PROTEIN-KINASE IS AN EARLY EVENT IN COLONIC CARCINOGENESIS
    CARTWRIGHT, CA
    MEISLER, AI
    ECKHART, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) : 558 - 562
  • [7] Characterization of two different cytoplasmic protein tyrosine kinases from human breast cancer
    Chedin, M
    Filhol, O
    Duminy, C
    Bolla, M
    Benistant, C
    Roche, S
    Chambaz, EM
    Cochet, C
    [J]. CARCINOGENESIS, 1997, 18 (08) : 1463 - 1472
  • [8] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [9] Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530
    Egan, C
    Pang, A
    Durda, D
    Cheng, HC
    Wang, JH
    Fujita, DJ
    [J]. ONCOGENE, 1999, 18 (05) : 1227 - 1237
  • [10] FANNING P, 1992, CANCER RES, V52, P1457